Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
09/2012
09/12/2012CN102114113B Preparation method of Chinese pulsatilla root decoction granules
09/12/2012CN102018792B Traditional Chinese medicine for treating ankylosing spondylitis
09/12/2012CN101781347B Polymorphic substances of decitabine and medical compositions
09/12/2012CN101760446B Method for preparing monocyte type stem cell and application
09/12/2012CN101646441B Suspension-type eye drop preparation comprising fluorometholone
09/12/2012CN101583598B Novel indole derivative having inhibitory activity on i kappa b kinase
09/12/2012CN101575340B Preparation method of ketorolac tromethamine
09/12/2012CN101524344B Compositions used for releasing the pain of skin
09/12/2012CN101325965B Use of transferrins for treating destructive inflammation of mucous membrane
09/11/2012US8263647 Treatment of sleep disturbances
09/11/2012US8263637 Methods for treatment of multiple myeloma using cyclopropane carboxylic acid {2-[(is)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1 h-isoindol-4-yl}-amide
09/11/2012US8263602 Matrix metalloproteinase inhibitors
09/11/2012US8263590 Pyrimidine derivatives
09/11/2012US8263579 Anti-inflammatory compounds
09/11/2012US8263349 Antibody specific for a mammalian sphingosine kinase type 2 isoform protein and methods of use thereof
09/11/2012US8263326 Compounds and methods for modulating activation of NF-κB
09/11/2012US8263118 Bioresorbable fillers constituted by phospholipid liposomes and hyaluronic acid and/or the derivatives thereof
09/11/2012US8263108 Biodegradable insert; drug delivery
09/11/2012US8263070 Using immunoglobulin specific to receptor for OX-2 membrane glycoprotein as diagnostic and therapeutic tool for treatment and prevention of asthma, infection, allergies, skin and cell proliferative disorders
09/11/2012US8262054 Furnace mount
09/11/2012CA2480881C Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
09/11/2012CA2474402C Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
09/11/2012CA2257247C Novel protein binding to osteoclastogenesis inhibitory factor and process for producing the same
09/07/2012WO2012119103A2 Compositions and methods for mobilization of stem cells
09/07/2012WO2012118813A2 Anti-il-6 receptor antibodies and methods of use
09/07/2012WO2012118124A1 Novel chemokine receptor antagonist
09/07/2012WO2012117969A1 Anti-inflammatory agent and process of producing same
09/07/2012WO2012117592A1 Therapeutic agent for hyperthermia
09/07/2012WO2012117062A1 Piperidinyl benzoimidazole derivatives as mpges-1 inihibitors
09/07/2012WO2012116666A1 Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin e2, method of production thereof and use thereof
09/07/2012WO2012116585A1 Pharmaceutical use of aminothiazole myd88 specificity inhibitor
09/07/2012WO2012116577A1 Chlorogenic acid analogue, preparation process and use thereof
09/07/2012WO2012116440A1 Benzimidazole inhibitors of the sodium channel
09/07/2012WO2011117145A3 Pyrrolopyrazine kinase inhibitors
09/07/2012CA2828796A1 Pharmaceutical use of aminothiazole myd88 specificity inhibitor
09/07/2012CA2828456A1 Benzimidazole inhibitors of the sodium channel
09/07/2012CA2827581A1 Anti-il-6 receptor antibodies and methods of use
09/06/2012US20120226347 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
09/06/2012US20120225937 Crystalline forms and processes for the preparation of pg12 receptor agonists
09/06/2012US20120225936 Method for producing triptolide
09/06/2012US20120225931 Compositions and methods for inhibiting inflammation from and rejection of biomaterials and other methods
09/06/2012US20120225916 Compositions and Methods to Improve Treatment of Medical Conditions Using D-Cycloserine
09/06/2012US20120225915 Compositions and Methods of Using R(+) Pramipexole
09/06/2012US20120225914 Treatment of sunburn using analgesics and antihistamines
09/06/2012US20120225905 Bepotastine compositions
09/06/2012US20120225890 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease
09/06/2012US20120225889 Use of macrocyclic lactone derivatives for the treatment of inflammatory disorders
09/06/2012US20120225885 Imidazole derivatives and methods of use thereof
09/06/2012US20120225883 Compounds for inflammation and immune-related uses
09/06/2012US20120225882 Selective hydroxamate based mmp inhibitors
09/06/2012US20120225879 Substituted 5-imino-1,2,4-thiadiazoles that can be used to treat neurodegenerative diseases
09/06/2012US20120225875 Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors
09/06/2012US20120225857 Mst1 kinase inhibitors and methods of their use
09/06/2012US20120225847 Squaric acid derivatives as inhibitors of the nicotinamide
09/06/2012US20120225828 Melanocortin-1 Receptor-Specific Cyclic Peptides
09/06/2012US20120225820 Peptides associated with hla-dr mhc class ii molecule and involved in rheumatoid arthritis
09/06/2012US20120225817 Therapeutic agent for gastrointestinal disease
09/06/2012US20120225812 Substituted fused pyrimidine compounds, its preparation and uses thereof
09/06/2012US20120225482 Mammalian cx3c chemokine antibodies
09/06/2012US20120225133 Use of an agent that restores tissue perfusion and oxygenation
09/06/2012US20120225128 Method for carrying therapeutic substances into cells
09/06/2012US20120225119 Therapeutic combination for painful medical conditions
09/06/2012US20120225118 Compositions for delivery of insoluble agents
09/06/2012US20120225117 Process for production of w/o/w emulsion, process for production of liposome employing the process, and porous membrane for use in the processes
09/06/2012US20120225114 Modifying Macrophage Phenotype for Treatment of Disease
09/06/2012US20120225107 Stable skin and scar treatment composition
09/06/2012US20120225101 Multifunctional in situ polymerized network via thiol-ene and thiol-maleimide chemistry
09/06/2012US20120225097 Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah)
09/06/2012US20120225088 Compositions and methods for treating cancer and other diseases
09/06/2012US20120225082 ADAM12 Inhibitors and Their Use Against Inflammation-Induced Fibrosis
09/06/2012US20120225069 Use of a compound for reducing the biological effectiveness of il-6
09/06/2012US20120225065 Anti-human il-21 monoclonal antibodies
09/06/2012US20120225058 Novel immunoglobulin insertions, deletions, and substitutions
09/06/2012US20120225057 Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases
09/06/2012US20120225053 Compositions and methods for the prevention and treatment of conditions associated with inflamation
09/06/2012US20120225032 Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo
09/06/2012US20120225031 Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders
09/06/2012US20120225030 Uses of mammalian cytokine; related reagents
09/06/2012US20120225028 Compositions and methods for mobilization of stem cells
09/06/2012US20120225012 Composition for hard tissue repair
09/05/2012EP2495244A1 Piperidinyl benzoimidazole derivatives as mPGEs-1 inhibitors
09/05/2012EP2494048A1 Method of treatment
09/05/2012EP2493910A1 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same
09/05/2012EP2493895A1 N-containing heteroaryl derivatives as jak3 kinase inhibitors
09/05/2012EP2493846A1 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them
09/05/2012EP2493491A1 Compositions including ginger for the amelioration or prevention of inflammatory conditions
09/05/2012EP2493469A2 Pharmaceutical composition comprising indole compound
09/05/2012EP2493465A2 Treatment of sunburn using analgesics and antihistamines
09/05/2012EP2493313A1 Kinase inhibitors
09/05/2012CN202409551U Traditional Chinese medicine ointment
09/05/2012CN1520424B Immunoglobulins 2
09/05/2012CN1514729B Sustained-release analgesic compounds
09/05/2012CN102656172A 8-oxodihydropurine derivative
09/05/2012CN102656140A 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them
09/05/2012CN102655868A Combination preparations comprising a cytokine antagonist and corticosteroid
09/05/2012CN102653515A Polycationic compounds and uses thereof
09/05/2012CN102653514A Chlorogenic acid analog, and preparation method and application thereof
09/05/2012CN102652818A Seahorse rheumatalgia-relieving plaster
09/05/2012CN102652817A Tortoise plastron and turtle plaster
09/05/2012CN102652793A Traditional Chinese medicine formula for activating muscles and bones
1 ... 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 ... 1272